The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors
Open accessAbstract
The concept for cellular immunotherapy of solid tumors relies heavily on the capacity of class I MHC-restricted cytotoxic T lymphocytes (CTLs) to eliminate tumor cells. However, tumors often have managed to escape from the cytolytic machinery of these effector cells. Therefore, it is very important to chart the mechanisms through which this escape can occur. Target-cell killing by CTLs involves the induction of apoptosis by two major mechanisms: through death receptors and the perforin/granzyme B (GrB) pathway. Whereas tumors previously were shown to exhibit mechanisms for blocking the death receptor pathway, we now demonstrate that they also can resist CTL-mediated killing through interference with the perforin/GrB pathway. This escape mechanism involves expression of the serine protease inhibitor PI-9/SPI-6, which inactivates the apoptotic effector molecule GrB. Expression of PI-9 was observed in a variety of human and murine tumors. Moreover, we show that, indeed, expression results in the resistance of tumor cells to CTL-mediated killing both in vitro and in vivo. Our data reveal that PI-9/SPI-6 is an important parameter determining the success of T cell-based immunotherapeutic modalities against cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Self-citationFas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
Lowin, B., Hahne, M., Mattmann, C., & Tschopp, J. (1994) · Nature · doi:10.1038/370650a0 · Cited by 1,051
Self-citationLin, K. Y., Guarnieri, F., Staveley-O’Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., & Wu, T. ‐. (1996) · PubMed · Cited by 1,003
Nagata, S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4834 · Cited by 905
Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H., & Ley, T. J. (1994) · Cell · doi:10.1016/0092-8674(94)90376-x · Cited by 812
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
The JAM test A simple assay for DNA fragmentation and cell death
Matzinger, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90325-a · Cited by 599
Corbett, T. H., Griswold, D. P., Roberts, B. J., Peckham, J. C., & Schabel, F. M. (1975) · PubMed · Cited by 584
Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
Decreased tumor surveillance in perforin-deficient mice.
van den Broek, M. E., Kägi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., Melief, C. J., Zinkernagel, R. M., & Hengartner, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1781 · Cited by 512
Self-citationBerke, G. (1995) · Cell · doi:10.1016/0092-8674(95)90365-8 · Cited by 501
Djerbi, M., Screpanti, V., Catrina, A. I., Bogen, B., Biberfeld, P., & Grandien, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.1025 · Cited by 421
Motyka, B., Korbutt, G., Pinkoski, M. J., Heibein, J. A., Caputo, A., Hobman, M., Barry, M., Shostak, I., Sawchuk, T., Holmes, C. F. B., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00140-9 · Cited by 398
Sutton, V. R., Davis, J. E., Cancilla, M., Johnstone, R. W., Ruefli, A. A., Sedelies, K., Browne, K. A., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1403 · Cited by 386
Kataoka, T., Shinohara, N., Takayama, H., Takaku, K., Kondo, S., Yonehara, S., & Nagai, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3678 · Cited by 377
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
Froelich, C. J., Orth, K., Turbov, J., Seth, P., Gottlieb, R., Babior, B., Shah, G. M., Bleackley, R. C., Dixit, V. M., & Hanna, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29073 · Cited by 358
Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein
Medema, J. P., de Jong, J., van Hall, T., Melief, C. J. M., & Offringa, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.1033 · Cited by 330
Self-citationA CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., & Bruggen, P. V. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.785 · Cited by 321
Granzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax
Heibein, J. A., Goping, I. S., Barry, M., Pinkoski, M. J., Shore, G. C., Green, D. R., & Bleackley, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1391 · Cited by 311
Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes
Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb, A. J., & Melief, C. J. M. (1989) · Cell · doi:10.1016/0092-8674(89)90006-8 · Cited by 301
Self-citationSun, J., Bird, C. H., Sutton, V., McDonald, L., Coughlin, P. B., De Jong, T. A., Trapani, J. A., & Bird, P. I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27802 · Cited by 297
Bird, C. H., Sutton, V. R., Sun, J., Hirst, C. E., Novak, A., Kumar, S., Trapani, J. A., & Bird, P. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6387 · Cited by 287
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60294-8 · Cited by 275
Kataoka, T., Schröter, M., Hahne, M., Schneider, P., Irmler, M., Thome, M., Froelich, C. J., & Tschopp, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3936 · Cited by 243
Self-citationShi, L., Mai, S., Israels, S., Browne, K., Trapani, J. A., & Greenberg, A. H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.855 · Cited by 235
DFF45/ICAD Can Be Directly Processed by Granzyme B during the Induction of Apoptosis
Thomas, D. A., Du, C., Xu, M., Wang, X., & Ley, T. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80213-7 · Cited by 213
Medema, J. P., Schuurhuis, D. H., Rea, D., van Tongeren, J., de Jong, J., Bres, S. A., Laban, S., Toes, R. E. M., Toebes, M., Schumacher, T. N. M., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.657 · Cited by 207
Self-citationShresta, S., MacIvor, D. M., Heusel, J. W., Russell, J. H., & Ley, T. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5679 · Cited by 202
A reassessment of the role of B7-1 expression in tumor rejection.
Wu, T. C., Huang, A. Y., Jaffee, E. M., Levitsky, H. I., & Pardoll, D. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1415 · Cited by 171
Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas
Peli, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1824 · Cited by 159
Bladergroen, B. A., Strik, M. C. M., Bovenschen, N., van Berkum, O., Scheffer, G. L., Meijer, C. J. L. M., Hack, C. E., & Kummer, J. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3218 · Cited by 157
Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo
Trapani, J. A., Davis, J. E., Sutton, V. R., & Smyth, M. J. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00094-7 · Cited by 138
Sun, J., Ooms, L. M., Bird, C. H., Sutton, V. R., Trapani, J. A., & Bird, P. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15434 · Cited by 105
Peter, M. E., Scaffidi, C., Medema, J. P., Kischkel, F. C., & Krammer, P. H. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69184-6_3 · Cited by 102
Self-citationProtective antitumor immunity induced by immunization with completely allogeneic tumor cells.
Toes, R. E. M., Blom, R. J. J., van der Voort, E., Offringa, R., Melief, C. J. M., & Kast, W. M. (1996) · PubMed · Cited by 86
Self-citationInhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
Fenton, R. G., Hixon, J. A., Wright, P. W., Brooks, A. D., & Sayers, T. J. (1998) · PubMed · Cited by 74
Valmori, D., Pittet, M. J., Vonarbourg, C., Rimoldi, D., Liénard, D., Speiser, D. E., Dunbar, P. R., Cerundolo, V., Cerottini, J. C., & Romero, P. J. (1999) · PubMed · Cited by 68
Seung, S. K., Urban, J. L., & Schreiber, H. W. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.933 · Cited by 60
Escape mechanisms in tumor immunity: a year 2000 update.
Pawelec, G., Heinzel, S., Kiessling, R. W., Müller, L., Ouyang, Q., & Zeuthen, J. (2000) · PubMed · Cited by 48
Cited by
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0136-1 · Cited by 5,179
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324
Functional significance of the perforin/granzyme cell death pathway
Trapani, J. A., & Smyth, M. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri911 · Cited by 1,291
Metadata
- Authors
- Medema, J. P., de Jong, J., Peltenburg, L. T. C., Verdegaal, E. M. E., Gorter, A., Bres, S. A., Franken, K. L. M. C., Hahne, M., Albar, J. P., Melief, C. J. M., & Offringa, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2001-09-18
- Volume
- 98
- Issue
- 20
- Pages
- 11515-11520
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2164296948
- Cited by
- 356
- References
- 43
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.